Alps Advisors Inc Ptc Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 58,169 shares of PTCT stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

58,169

Previous 59,818 2.76%

Holding current value

$2.28 Million

Previous $1.83 Million 17.99%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.39 - $37.66 $50,113 - $62,101	-1,649 Reduced 2.76%	58,169 $2.16 Million
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $1.48 Million - $2.4 Million	59,818 New	59,818 $1.83 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $137,853 - $177,381	-3,294 Reduced 7.78%	39,030 $1.96 Million
Q2 2022 Aug 11, 2022	SELL	$25.6 - $45.23 $794,060 - $1.4 Million	-31,018 Reduced 42.29%	42,324 $1.7 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $282,438 - $377,940	-8,474 Reduced 10.36%	73,342 $2.74 Million
Q4 2021 Feb 09, 2022	SELL	$35.36 - $41.86 $166,722 - $197,369	-4,715 Reduced 5.45%	81,816 $3.26 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $220,801 - $266,918	-5,966 Reduced 6.45%	86,531 $3.22 Million
Q2 2021 Aug 11, 2021	SELL	$37.95 - $49.37 $1.32 Million - $1.71 Million	-34,731 Reduced 27.3%	92,497 $3.91 Million
Q1 2021 May 07, 2021	BUY	$46.8 - $68.92 $227,167 - $334,537	4,854 Added 3.97%	127,228 $6.02 Million
Q4 2020 Feb 03, 2021	BUY	$47.96 - $67.64 $1.73 Million - $2.44 Million	36,031 Added 41.73%	122,374 $7.47 Million
Q3 2020 Nov 04, 2020	BUY	$45.41 - $57.07 $26,019 - $32,701	573 Added 0.67%	86,343 $4.04 Million
Q2 2020 Aug 05, 2020	SELL	$42.56 - $54.98 $1.11 Million - $1.43 Million	-25,993 Reduced 23.26%	85,770 $4.35 Million
Q1 2020 May 06, 2020	SELL	$32.37 - $59.36 $399,769 - $733,096	-12,350 Reduced 9.95%	111,763 $4.99 Million
Q4 2019 Feb 07, 2020	BUY	$32.22 - $50.07 $209,526 - $325,605	6,503 Added 5.53%	124,113 $5.96 Million
Q3 2019 Nov 04, 2019	SELL	$33.82 - $48.17 $142,585 - $203,084	-4,216 Reduced 3.46%	117,610 $3.98 Million
Q2 2019 Aug 07, 2019	SELL	$35.42 - $45.0 $589,317 - $748,710	-16,638 Reduced 12.02%	121,826 $5.48 Million
Q1 2019 May 01, 2019	BUY	$28.09 - $39.49 $614,103 - $863,330	21,862 Added 18.75%	138,464 $5.21 Million
Q4 2018 Feb 04, 2019	BUY	$29.83 - $46.51 $1.01 Million - $1.58 Million	33,936 Added 41.05%	116,602 $4 Million
Q3 2018 Oct 25, 2018	BUY	$33.9 - $47.77 $517,347 - $729,017	15,261 Added 22.64%	82,666 $3.89 Million
Q2 2018 Aug 02, 2018	BUY	$25.7 - $47.88 $550,751 - $1.03 Million	21,430 Added 46.61%	67,405 $2.27 Million
Q2 2018 Jul 25, 2018	SELL	$25.7 - $47.88 $248,596 - $463,143	-9,673 Reduced 17.38%	45,975 $767,000
Q1 2018 May 01, 2018	BUY	$17.46 - $32.59 $168,890 - $315,243	9,673 Added 21.04%	55,648 $1.51 Million
Q4 2017 Feb 05, 2018	BUY	$15.14 - $20.89 $78,924 - $108,899	5,213 Added 12.79%	45,975 $767,000
Q3 2017 Nov 03, 2017	BUY	$16.81 - $21.61 $685,209 - $880,866	40,762	40,762 $816,000

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Ptc Therapeutics, Inc. Transaction History